MEDL Signs LOI to Bring Innovation Protection to Mobile App Developers

MEDL Signs LOI to Bring Innovation Protection to Mobile App Developers

Mobile Pioneer Protects Its Growing Alliance of App Developers From the Murky
Waters of Intellectual Property Infringement

FOUNTAIN VALLEY, Calif., Nov. 19, 2012 (GLOBE NEWSWIRE) -- MEDL Mobile,
Inc.(OTCBB:MEDL) – a pioneer in the creation, development, marketing and
monetization of mobile apps – announced that it has signed a Letter of Intent
with MacroSolve, Inc., (OTCQB:MCVE), a leading provider of mobile technology
intellectual property.

As the mobile ecosystem evolves, the threat of litigation from holders of
patented technologies is quickly surfacing as a major danger to small and
mid-sized developers who are not equipped to navigate the complexities of this
new terrain. MEDL Mobile is crafting an agreement with MacroSolve, the holder
of a key mobile technology patent with far-reaching implications, to create a
program that provides a simple and affordable solution for app developers.

"MEDL's goal is to provide an ever increasing library of tools and services to
our growing Developer Network with our proprietary SDK," said Andrew Maltin,
MEDL Mobile CEO. "This new relationship will allow MEDL to offer an entirely
new tier of services - one that was previously out of reach for most small and
mid-sized developers."

The patent addresses mobile information collection systems across all wireless
networks, smart phones, tablets, and rugged mobile devices, regardless of
carrier and manufacturer. MacroSolve's patent covers fundamental technology in
the mobile application space utilized by multiple companies.

MacroSolve Chairman and CEO Jim McGill states, "MEDL is the first visionary
partner to provide the benefits of the '816' patent to thousands of app
developers. Our joint business model is designed to be scalable, profitable
and simple to implement, for the advantage of both companies."

On October 26, 2010, the United States Patent and Trademark Office issued U.S.
Patent No. 7,822,816 to MacroSolve. The patent, a significant intellectual
property asset to MacroSolve, further advances its position as a leader in the
mobile solutions market.

About MEDL Mobile

The Company develops, acquires and publishes a growing library of mobile
applications which perform specific functions for the user on the Apple and
Android platforms. The Company licenses its technology and performs custom
development for key clients such as, New York Times Company,
Teleflora, Telefonica and Medtronic, allowing the company to grow the overall
library of technology greatly extending the potential reach of the Mobile
Brain. The Company enters into partnerships to mobilize and monetize IP with
such notable names as Encyclopedia Britannica, MTV's Pauly D, Cheech & Chong,
Rampage Jackson and Marlee Matlin. The Company is establishing a business
model in which it expects to generate multiple revenue streams, including
development fees, download and in-app purchases, advertising, sponsorship and
licensing of technology. User analytics are collected by the Company's growing
Mobile Brain which processes user data in order to create better distribution
and monetization of mobile applications. The Company's Software Development
Kit (SDK) consists of a growing suite of tools which have been designed to
help developers to better market and monetize their mobile applications. For
more information about MEDL Mobile, please visit

The MEDL Mobile Holdings Inc. logo is available at

About MacroSolve

Founded in 1997, MacroSolve is heralded for its robust IP portfolio, while
advancing throughout the mobile apps era by innovating key technologies that
have laid the foundation for apps and next-gen developers. Today, MacroSolve
is empowering a new era of mobile innovators seeking advisory services and IP
strength from a source of experience.

Forward-Looking Statements

Certain statements contained herein constitute "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on current expectations, estimates
and projections about MEDL Mobile's industry, management's beliefs and certain
assumptions made by management. Readers are cautioned that any such
forward-looking statements are not guarantees of future performance and are
subject to certain risks, uncertainties and assumptions that are difficult to
predict. Because such statements involve risks and uncertainties, the actual
results and performance of the Company may differ materially from the results
expressed or implied by such forward-looking statements. Given these
uncertainties, readers are cautioned not to place undue reliance on such
forward-looking statements. Potential risks and uncertainties include but are
not limited to the ability to integrate Inedible Software apps and platform
into MEDL's product offering, the ability to procure, properly price, retain
and successfully complete projects, and changes in products and competition.
Unless otherwise required by law, the Company also disclaims any obligation to
update its view of any such risks or uncertainties or to announce publicly the
result of any revisions to the forward-looking statements made here. Readers
should review carefully reports or documents the Company files periodically
with the Securities and Exchange Commission.

For more information about MEDL Mobile, please visit

CONTACT: Media Contact:
         DJ Swanepoel
         MEDL Mobile
         Investor Relations Contact:
         RedChip Companies, Inc.
         Jon Cunningham
         800-733-2447, Ext. 107
         407-644-4256, Ext. 107

company logo
Press spacebar to pause and continue. Press esc to stop.